1. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications
   Rossella De Florian Fania et al, 2024, Cell Death & Differentiation CrossRef
2. Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle
   Nidhi N. Shah et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
3. Akt scaffold proteins: the key to controlling specificity of Akt signaling
   Fan Bao et al, 2021, American Journal of Physiology-Cell Physiology CrossRef
4. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression
   Disha V. Pandya et al, 2024, Molecular Biology Reports CrossRef
5. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells
   Yifan Duan et al, 2020, Technology in Cancer Research & Treatment CrossRef
6. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
   Guannan Wang et al, 2021, OncoTargets and Therapy CrossRef
7. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway
   Jingjing Zhang et al, 2020, Anti-Cancer Drugs CrossRef
8. Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer
   Afshin Nikkhoo et al, 2019, Journal of Cellular Biochemistry CrossRef